Taking a Look at the Data Behind Rite Aid Corporation (RAD)

Rite Aid Corporation (RAD) is an interesting player in the Services space, with a focus on Drug Stores. The stock has been active on the tape, currently trading at $1.71, up from yesterday’s close by 0.59%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Rite Aid Corporation (RAD) currently trades with a market capitalization of $1.85 Billion. That value represents a market adjusting for revenues that have been falling by -5.57 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of $253.54 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of -$0.01 on a per share basis this quarter. Perhaps, that suggests something about why 1.68% of the outstanding share supply is held by institutional investors.

Technical Analysis

No analysis is ever complete without a thorough survey of a stock’s technical behavior. Looking at the stock’s movement on the chart, Rite Aid Corporation recorded a 52-week high of $5.15. It is now trading 3.44% off that level. The stock is trading $2.07 its 50-day moving average by 0.36%. The stock carved out a 52-week low down at $1.38.

In recent action, Rite Aid Corporation (RAD) has made a move of -14.50% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 16.68, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 11.14% with $1.06 Billion sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of RAD.

Previous articleJust the Facts on BioPharmX Corporation (BPMX)
Next articleDigging Up the Facts on HP Inc. (HPQ)